Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Globularia cordifolia is a perennial flowering plant native to the mountains of central and southern Europe, commonly known as heart-leaved globe daisy. Extracts from this plant, including callus culture extracts, are rich in phenolic compounds and flavonoids. Scientific studies have demonstrated that Globularia cordifolia extract exhibits strong antioxidant, anti-inflammatory, and antiproliferative properties. In vitro research has shown significant cytotoxic effects against colon cancer cells and a reduction in pro-inflammatory cytokines[1][9]. The extract also demonstrates effective iron chelation capacity and high total phenolic content[1]. In cosmetics, callus culture extracts (sometimes marketed under trade names like Resistem) are used for their skin-soothing effects—reducing redness, supporting skin regeneration, protecting against oxidative stress, detoxifying damaged proteins from the skin surface, and potentially increasing superoxide dismutase activity[2][3][5][6]. Traditional uses of Globularia species include diuretic, laxative, stomachic applications as well as treatment for hemorrhoids in folk medicine[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on globularia cordifolia.